From the Research
Dosage of Norco for Herpes Zoster
There are no specific studies that provide guidance on the appropriate dosage of Norco (hydrocodone and acetaminophen) for herpes zoster. However, the following information can be gathered from the available studies:
- The study 1 discusses the management of zoster-associated pain, but does not provide specific dosage recommendations for Norco.
- The study 2 compares the analgesic efficacy and tolerability of codeine phosphate versus hydrocodone bitartrate in combination with acetaminophen in the relief of cancer-related pain, and reports that the total daily doses used were 150/2500 mg and 25/2500 mg, respectively.
- The study 3 mentions that the FDA has limited the amount of acetaminophen in each dose of hydrocodone to 325 mg, but does not provide specific dosage recommendations for Norco in the treatment of herpes zoster.
- The study 4 reports on the patterns of use of immediate-release hydrocodone/acetaminophen, but does not provide specific dosage recommendations for Norco in the treatment of herpes zoster.
- The study 5 discusses the change in prescription habits after the federal rescheduling of hydrocodone combination products, but does not provide specific dosage recommendations for Norco in the treatment of herpes zoster.
Key Points
- There is no specific guidance on the appropriate dosage of Norco for herpes zoster.
- The available studies provide information on the management of pain, but do not specifically address the treatment of herpes zoster with Norco.
- The FDA has limited the amount of acetaminophen in each dose of hydrocodone to 325 mg 3.
- The patterns of use of immediate-release hydrocodone/acetaminophen have been reported, but do not provide specific dosage recommendations for Norco in the treatment of herpes zoster 4.